Replies to post #116233 on NanoViricides Inc. (NNVC)

[Nanotoday]

The company has stated that any and all new 'cide material will go EXCLUSIVELY towards herpecide.

Yes, scale up is a "parallel" path for both Flucide and herbicide, but Flucide Tox will not get a drop until Herpecide is in Tox. Given that they have not met with the FDA to get their guidance on the TOX panel requirements, even though topical Tox likely requires less material and is shorter, it won't start until Q3 '16 at the earliest. Even if they had gallons of the stuff today, no Tox until another pre-inda FDA meeting.

I wonder what the next treatment that gets "laser like" focus will be? Or as I like to call it: the next "flavor of the month."


These guys are good!

[JG36]

How is what you posted in any way relevant to the real problems that NNVC has? Namely, it's inability to actually make the 'cides.

And the fact that any drug that looks promising in mice can still fail in humans.